UVA CLEAR Clinical Trials
UVA CLEAR is currently conducting the following studies:
- High and Low Dose Topiramate for the Treatment of Alcohol-Dependent Smokers
- Trial of the Safety and Efficacy of HORIZANT (Gabapentin Enacarbil) for the Treatment of Alcohol Use Disorder
UVA CLEAR is developing further studies for alcohol dependence, cocaine dependence, as well as marijuana and nicotine. We plan on conducting more research studies in the coming years to help develop new medications for the treatment of substance abuse.